US Broker Ratings

Inventiva S.A. (IVA): Unpacking the 145% Upside Potential in Biotech’s Promising Contender

Inventiva S.A. (NASDAQ: IVA), a French biopharmaceutical company, is garnering significant attention in the biotechnology sector. With a market capitalization of $1.21 billion, the company is making waves primarily due..

Precigen, Inc. (PGEN) Stock Analysis: 87% Upside Potential Ignites Investor Interest

Precigen, Inc. (NASDAQ: PGEN) is capturing the attention of investors with a compelling 87.64% potential upside, as indicated by its average target price. This biopharmaceutical company, specializing in gene and..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 111.97% Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a leader in regenerative medicine, is capturing investor attention with its impressive growth potential. With a market cap of $508.92 million, this U.S.-based company operates..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Eyeing a 119% Upside with a Strong Buy Consensus

Gyre Therapeutics, Inc. (GYRE) stands out in the biotechnology sector with a compelling story for growth-oriented investors. Headquartered in San Diego, California, this pharmaceutical company is making waves in the..

SI-BONE, Inc. (SIBN) Stock Analysis: Aiming for a 53% Upside With Innovative Medical Solutions

SI-BONE, Inc. (NASDAQ: SIBN) is making waves in the healthcare sector, specifically in the medical devices industry. Known for its innovative approach to addressing musculoskeletal disorders, the company has positioned..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: A Healthcare Play with Robust Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the U.S. medical care facilities sector, has garnered attention with its robust 25.90% revenue growth. Based in Dallas, Texas, this company,..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 277% Upside Potential in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) commands attention in the biotechnology sector with its innovative approach to drug discovery and development, leveraging its proprietary GEODe technology platform. With a current market..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Potential Upside Amidst Volatile Valuation

Investors with an eye on the biotechnology sector may find Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) a curious case study. With a market cap of $564.09 million, Ginkgo operates in..

AbCellera Biologics Inc. (ABCL) Investor Outlook: Unveiling a Potential 154.75% Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology firm, is making waves in the healthcare sector with its innovative approach to antibody drug discovery. At its current price of $3.86,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech’s Promising Prospects with 5.7% Upside Potential

Sionna Therapeutics, Inc. (NASDAQ: SION) is making waves in the healthcare sector, specifically within the biotechnology industry, as it seeks to revolutionize the treatment of cystic fibrosis (CF). With a..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A Biotech Powerhouse with 34.79% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology arena, with its focus on precision therapies for genetically defined diseases. Headquartered in Waltham, Massachusetts, Cogent is carving out..

Akso Health Group (AHG) Stock Analysis: Exploring the 415.8% Revenue Surge and Its Implications for Investors

Akso Health Group (NASDAQ: AHG), a dynamic player in the healthcare sector, is garnering attention with its remarkable 415.8% revenue growth. This surge raises important considerations for investors keen on..

Semler Scientific, Inc. (SMLR): Investor Outlook on a 258% Potential Upside in the Healthcare Sector

Semler Scientific, Inc. (NASDAQ: SMLR) has captured investor attention with a remarkable potential upside of 258.65%, as indicated by current analyst ratings. Despite the healthcare sector’s notorious volatility, this figure..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotech Sector with Strategic Collaborations

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the biotechnology sector, is capturing attention with its strategic partnerships and service offerings in clinical development. With a market capitalization of..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 40% Potential Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, presents a promising opportunity for investors seeking to delve into the dynamic biotechnology sector. With a market capitalization of $794.3 million,..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 246% Potential Upside in the Biotech Arena

Altimmune, Inc. (NASDAQ: ALT) has captured the attention of investors with a staggering potential upside of 246.41%, according to recent analyst ratings. Specializing in the healthcare sector, specifically in biotechnology,..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 28.30% Potential Upside in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents a compelling case for investors with a noted potential upside..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution

Owens & Minor, Inc. (NYSE: OMI), a prominent player in the medical distribution industry, offers a compelling investment opportunity with a potential upside of 94.29%. Operating within the healthcare sector,..

Iovance Biotherapeutics (IOVA): Investor Outlook Reveals 217% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is carving out its niche in the competitive biotechnology sector with a focus on innovative cell therapies for cancer treatment. Headquartered in San Carlos, California,..

COMPASS Pathways Plc (CMPS): Investor Outlook Reveals 154% Potential Upside

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering entity in the healthcare sector, has carved out a niche in the burgeoning field of mental health treatment. Specializing in innovative therapies, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds